SCHEMBL5207795

SCHEMBL5207795

CC(C)n1nc(CO)c(Cc2cccs2)c1Sc1cc(Cl)cc(Cl)c1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADCY10 Q96PN6 2/20 0.36
ALDH1A1 P00352 5/20 0.34
GAA P10253 1/20 0.34
SMN1; SMN2 Q16637 4/20 0.33
MAPT P10636 3/20 0.33
NPSR1 Q6W5P4 3/20 0.33
CDK4 P11802 1/20 0.33
CCND1 P24385 1/20 0.33
LMNA P02545 3/20 0.31
HPGD P15428 2/20 0.31
NPC1 O15118 2/20 0.31
RAB9A P51151 2/20 0.31
POLB P06746 2/20 0.31
HIF1A Q16665 2/20 0.31
MEN1 O00255 2/20 0.30
KMT2A Q03164 2/20 0.30
PKM P14618 1/20 0.30
STAT6 P42226 1/20 0.30
L3MBTL1 Q9Y468 1/20 0.30
KDM4E B2RXH2 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5239631 0.85 ADCY10 (0.39) ADCY10ALDH1A1GAASMN1; SMN2MAPT
SCHEMBL5211738 0.82 POLB (0.33) SMN1; SMN2POLB
SCHEMBL5211288 0.82 FLT1 (0.35) ALDH1A1CDK4CCND1PKM
SCHEMBL5209455 0.80 CYP1A2 (0.31) POLB
SCHEMBL5208599 0.78 CACNA1H (0.32)
SCHEMBL5214219 0.78 FPR1 (0.39) ADCY10ALDH1A1MAPTCDK4CCND1
SCHEMBL14564994 0.77 FLT1 (0.33) CDK4CCND1
SCHEMBL5207787 0.76 FLT1 (0.33)
SCHEMBL5208321 0.76 PDE4D (0.36) ALDH1A1GAASMN1; SMN2MAPTNPSR1
SCHEMBL5211866 0.75

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1401826-B1 PYRAZOLE DERIVATIVES AS HIV REVERSE TRANSCRIPTASE INHIBITORS HOFFMANN LA ROCHE (CH) 2007-03-21 EP claimed
EP-1401826-A1 PYRAZOLE DERIVATIVES AS HIV REVERSE TRANSCRIPTASE INHIBITORS F. HOFFMANN-LA ROCHE AG (CH) 2004-03-31 EP claimed
US-6538015-B1 Process for their manufacture, pharmaceutical compositions and the use of such compounds in medicine. In particular, the compounds of formula I are inhibitors of the human immunodeficiency virus reverse transcriptase enzyme which is HOFFMANN-LA ROCHE INC. 2003-03-25 US claimed
WO-2002100853-A1 PYRAZOLE DERIVATIVES AS HIV REVERSE TRANSCRIPTASE INHIBITORS F. HOFFMANN-LA ROCHE AG (CH) 2002-12-19 WO claimed